Clinical trial No longer in our active list Interventional Ages 18 and up

Evaluating management options after anterior cruciate ligament rupture

Official title: Effect of Informing the Patient on the Type of Management, Surgical or Functional, After Rupture of the Anterior Cruciate Ligament : INFO-LCA

Run by GCS Ramsay Santé pour l'Enseignement et la Recherche · NCT05585528 · Data updated 2026-05-14

This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.

This study is trying to see how many people with a recent ACL tear choose to manage it with physical therapy or surgery after learning about their options, and how their choices affect their recovery over a year.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment200 (estimated)
SponsorGCS Ramsay Santé pour l'Enseignement et la Recherche
Academic / other
Locations1 site (Lyon)
Trial IDNCT05585528 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are individuals with a recent ACL rupture confirmed by MRI, who are able to understand the study information and consent to participate.

Probably not a fit

Patients with severe associated ligament injuries, symptomatic meniscal lesions, or those engaged in competitive sports may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to assess how many patients with a recent anterior cruciate ligament (ACL) rupture choose functional or surgical management after receiving detailed information about their options. Patients will be monitored for one year, with regular evaluations of their functional status and quality of life at multiple time points. The study will also track those who may require surgery later due to functional instability or personal choice. The goal is to inform better management strategies based on patient preferences and outcomes.

Why it matters

Potential benefit: If successful, this study could help patients make more informed decisions about their treatment options for ACL injuries.

How similar studies have gone: While there have been studies on ACL management, this specific approach focusing on patient-informed decision-making is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Rupture, partial or complete, of the anterior cruciate ligament less than 3 months old (confirmed by magnetic resonance imaging);
* Patient with no contraindication to surgery or functional management, according to the medical team;
* Patient able to understand the information related to the study, to read the information leaflet and having consented to participate in the study
* Patient benefiting from a social security scheme;

Exclusion Criteria:

* Grade 3 associated ligament injury on the fibular collateral ligament and/or the tibial collateral ligament;
* Symptomatic meniscal lesion;
* Practice of sport in national or international competition ;
* Recurrence of rupture of the same anterior cruciate ligament;
* Patient with a neurological (motor and/or sensory), vestibular or rheumatic pathology;
* Pregnant woman ;
* Protected adult patient (under guardianship, or under a regime of deprivation of liberty).

Where it's running

  • Clinique de la Sauvegarde
    Lyon, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.